Page 79 - கொலம்பியா பல்கலைக்கழகம் இவிஂக் மருத்துவ மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Patients on ACE inhibitors, ARBs, don t have higher COVID-19 risk

Patients on ACE inhibitors, ARBs, don t have higher COVID-19 risk
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesFort detrickMarca suchardGeorge hripcsakDaniel moralesSpain columbia university irving medical centerEuropean network of centresInformation system for researchDepartment of veteran affairsResearch facilityColumbia university department of biomedical informaticsWellcome trust clinical researchLancet digital healthEuropean medicines agencyObservational health data sciencesUniversity of dundee

Patients on ACE inhibitors, ARBs, don t have higher COVID-19 risk, fFnds study

E-Mail NEW YORK, NY (Dec. 17, 2020) While the COVID-19 pandemic left the world searching for answers during the earliest stages of the pandemic, one immediate healthcare concern regarded the use of certain antihypertensives and whether they posed increased risks to patients with hypertension. A new study by global collaborators within the Observational Health Data Sciences and Informatics (OHDSI) community found that there was no increased risk of COVID-19 diagnosis, hospitalization, or subsequent complications for users of either angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) among an international cohort of more than 1.1 million patients using antihypertensives. The study was published today in

United statesMarca suchardGeorge hripcsakDaniel moralesSpain columbia university irving medical centerEuropean network of centresInformation system for researchColumbia universityDepartment of veteran affairsColumbia university department of biomedical informaticsWellcome trust clinical researchLancet digital healthEuropean medicines agencyObservational health data sciencesUniversity of dundeeLancet digital

Mohs Skin Cancer Surgery Facts

Mohs Skin Cancer Surgery Facts © (Getty Images) A female doctor sits at her office and examining elderly female patient Skin cancer is the most common type of cancer in the U.S. In fact, one in five Americans are projected to develop skin cancer over their lifetime, according to the American Academy of Dermatology. Because your face, neck and hands are easily exposed to sun, these areas are more vulnerable to skin cancer. Many dermatologic surgeons are trained to use a technique called Mohs micrographic surgery to remove skin cancer. With Mohs, the surgeon can remove the skin cancer with a narrow margin of normal skin and then examine the skin cancer under a microscope to see if it s fully removed, says Dr. Jesse M. Lewin, Mohs micrographic/dermatologic surgeon and director of dermatologic surgery education at Columbia University Irving Medical Center in New York. The surgeon can remove more skin cancer if needed from the target area. Mohs is named after the surgeon, Dr. Frede

New yorkUnited statesSan diegoS brian jiangJennifer lucasFrederic mohsJessem lewinColumbia university irving medical centerSkin cancer foundationUniversity of californiaAmerican academy of dermatologyGetty imagesAmerican academySkin cancerCleveland clinicExpect during mohs

SWEDEPAD: No Mortality Signal With Paclitaxel in PAD

December 18, 2020 An unplanned interim analysis from a study that was halted in the aftermath of concerns about paclitaxel shows no difference in rates of long-term all-cause mortality between patients with PAD treated with coated or uncoated devices, regardless of the extent of limb disease. The SWEDEPAD trialists, along with those from the BASIL-3 study, paused recruitment following publication of a meta-analysis in late 2018 by Konstantinos Katsanos, MD, PhD (Patras University Hospital, Rion, Greece), and colleagues. The controversial meta-analysis reported a 68% relative increase in risk of all-cause death with paclitaxel-coated devices versus uncoated devices at 2 years and a 93% relative risk increase by 5 years in those with femoral and/or popliteal artery disease.

New yorkUnited statesVastra gotalands lanJoakim nordanstigSahil parikhKonstantinos katsanosDrug administrationPresbyterian columbia university irving medical centerPhd patras university hospitalPhd gothenburg universityPatras university hospitalGothenburg universityNew england journalColumbia university irving medical centerபுதியது யார்க்ஒன்றுபட்டது மாநிலங்களில்

COVID-19 is the big story in mortality statistics — but not the only one

COVID-19 is the big story in mortality statistics — but not the only one
petoskeynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from petoskeynews.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkMitchell elkindSteven woolfCenters for diseaseVirginia commonwealth university in richmondAmerican heart associationCenter on societyUniversity of southern californiaJohns hopkins coronavirus resource centerPresbyterian hospital columbia university irving medical centerJohns hopkins coronavirus resourceDisease controlVirginia commonwealth universityColumbia university irving medical centerNew york city